The Deal Register
Database › M&A › High Tide Closes Acquisition of a Majority Stake in Remexian Pharma…

M&A

High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH

Lane
M&A
Announced
02 Sep 2025
Province
Alberta
Industry
Healthcare & life sciences
Status
Announced
What the filing says
High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI ) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce, that further to its press release dated August 14, 2025 (the " August 14 Release"), the Company has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of €26.4 million, such amount to be finalized in 30 days, once the final closing balance sheet is available, and will have a five-year option to acquire the remaining 49% of Remexian at…
Terms stated
maturity date, multiple EBITDA, price per security, VWAP reference
Releases (2)
  • 14 Aug 2025 — High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH
  • 02 Sep 2025 — High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH
Source

The terms are in the subscriber edition

This transaction carries 4 stated terms, with the value, unit and basis of each.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe